Pfizer's new drug is going to the dogs

Leaders from Glossier, Shopify, Mastercard and more will take the stage at Brandweek to share what strategies set them apart and how they incorporate the most valued emerging trends. Register to join us this September 23–26 in Phoenix, Arizona.


Alright, this is just so wrong on so many levels: Pfizer has received government approval to market a weight loss pill for dogs. Slentrol, however, could cause vomiting and diarrhea in dogs for whom it is prescribed, researchers warn. They also acknowledge that an obese dog (one which is 20 percent more than its ideal weight) doesn’t get that way by himself. Duh. It’s not like they have money to go buy beer or can open the fridge on their own.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in